Middle East & Africa Ivd In Cardiology And Neurology Market Size & Outlook
Middle East & Africa ivd in cardiology and neurology market, 2018-2030 (US$M)
Related Markets
MEA ivd in cardiology and neurology market highlights
- The MEA ivd in cardiology and neurology market generated a revenue of USD 541.2 million in 2022.
- The market is expected to grow at a CAGR of 8.8% from 2023 to 2030.
- In terms of segment, reagents & consumables was the largest revenue generating product in 2022.
- Reagents & Consumables is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, UAE is expected to register the highest CAGR from 2023 to 2030.
MEA data book summary
| Market revenue in 2022 | USD 541.2 million |
| Market revenue in 2030 | USD 1,058.7 million |
| Growth rate | 8.8% (CAGR from 2022 to 2030) |
| Largest segment | Reagents & consumables |
| Fastest growing segment | Reagents & Consumables |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Reagents & Consumables, Software and Services |
Other key industry trends
- In terms of revenue, MEA region accounted for 3.6% of the global ivd in cardiology and neurology market in 2022.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Latin America is the fastest growing regional market and is projected to reach USD 1,508.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
IVD In Cardiology And Neurology Market Scope
IVD In Cardiology And Neurology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Middle East & Africa ivd in cardiology and neurology market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ivd in cardiology and neurology market will help companies and investors design strategic landscapes.
Reagents & consumables was the largest segment with a revenue share of 65.72% in 2022. Horizon Databook has segmented the Middle East & Africa ivd in cardiology and neurology market based on instruments, reagents & consumables, software and services covering the revenue growth of each sub-segment from 2018 to 2030.
- Middle East & Africa IVD In Cardiology And Neurology Product Outlook (Revenue, USD Million, 2018-2030)
- Instruments
- Reagents & Consumables
- Software and Services
- Middle East & Africa IVD In Cardiology And Neurology Technology Outlook (Revenue, USD Million, 2018-2030)
- Immunoassays
- Molecular Diagnostics
- Hematology
- Other Technology
- Middle East & Africa IVD In Cardiology And Neurology End Use Outlook (Revenue, USD Million, 2018-2030)
- Hospitals
- Clinical Laboratories
- Other End-use
Reasons to subscribe to Middle East & Africa ivd in cardiology and neurology market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa ivd in cardiology and neurology market databook
-
Our clientele includes a mix of ivd in cardiology and neurology market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa ivd in cardiology and neurology market, including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa ivd in cardiology and neurology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA in vitro diagnostics cardiology neurology market report size, by country, 2018-2030 (US$M)
Middle East & Africa IVD In Cardiology And Neurology Market Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
